PSMB3P2

Across TCGA pan-cancer cohorts, PSMB3P2 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of PSMB3P2’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where PSMB3P2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types PSMB3P2 is over-expressed in tumor, although a few such as KIRC show the opposite, repressed pattern.

COAD, ESCA, and KIRC are the cancer types where PSMB3P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in PSMB3P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	+0.091	.011	3	view →
ESCA	Male	All	+0.396	.041	2	view →
KIRC	Female	III,IV	−0.040	.010	2	view →
LIHC	All	All	+0.038	.029	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

PSMB3P2–COAD

Open the COAD breakdown →